BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 26075717)

  • 1. Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms.
    Toyoshima A; Yasuhara T; Kameda M; Morimoto J; Takeuchi H; Wang F; Sasaki T; Sasada S; Shinko A; Wakamori T; Okazaki M; Kondo A; Agari T; Borlongan CV; Date I
    PLoS One; 2015; 10(6):e0127302. PubMed ID: 26075717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical Stimulation Enhances Migratory Ability of Transplanted Bone Marrow Stromal Cells in a Rodent Ischemic Stroke Model.
    Morimoto J; Yasuhara T; Kameda M; Umakoshi M; Kin I; Kuwahara K; Kin K; Okazaki M; Takeuchi H; Sasaki T; Toyoshima A; Tajiri N; Agari T; Borlongan CV; Date I
    Cell Physiol Biochem; 2018; 46(1):57-68. PubMed ID: 29587284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.
    Liu N; Zhang Y; Fan L; Yuan M; Du H; Cheng R; Liu D; Lin F
    J Transl Med; 2011 Jul; 9():105. PubMed ID: 21733181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats.
    Dabrowska S; Andrzejewska A; Strzemecki D; Muraca M; Janowski M; Lukomska B
    J Neuroinflammation; 2019 Nov; 16(1):216. PubMed ID: 31722731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.
    Nam HS; Kwon I; Lee BH; Kim H; Kim J; An S; Lee OH; Lee PH; Kim HO; Namgoong H; Kim YD; Heo JH
    PLoS One; 2015; 10(12):e0144218. PubMed ID: 26637168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke.
    Yabuno S; Yasuhara T; Nagase T; Kawauchi S; Sugahara C; Okazaki Y; Hosomoto K; Sasada S; Sasaki T; Tajiri N; Borlongan CV; Date I
    Stem Cell Res Ther; 2023 Jan; 14(1):10. PubMed ID: 36691091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats.
    Lee SH; Jin KS; Bang OY; Kim BJ; Park SJ; Lee NH; Yoo KH; Koo HH; Sung KW
    PLoS One; 2015; 10(8):e0134920. PubMed ID: 26241653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats.
    Zhang HL; Xie XF; Xiong YQ; Liu SM; Hu GZ; Cao WF; Wu XM
    Brain Res; 2018 Feb; 1680():143-154. PubMed ID: 29274877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke.
    Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA
    Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conditioned medium of human embryonic stem cell-derived mesenchymal stem cells alleviates neurological deficits and improves synaptic recovery in experimental stroke.
    Asgari Taei A; Dargahi L; Nasoohi S; Hassanzadeh G; Kadivar M; Farahmandfar M
    J Cell Physiol; 2021 Mar; 236(3):1967-1979. PubMed ID: 32730642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats.
    Ikeda N; Nonoguchi N; Zhao MZ; Watanabe T; Kajimoto Y; Furutama D; Kimura F; Dezawa M; Coffin RS; Otsuki Y; Kuroiwa T; Miyatake S
    Stroke; 2005 Dec; 36(12):2725-30. PubMed ID: 16282547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
    Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
    J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion.
    Nazarian S; Abdolmaleki Z; Torfeh A; Shirazi Beheshtiha SH
    Exp Brain Res; 2020 Nov; 238(11):2589-2601. PubMed ID: 32886135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal neural crest stem cell transplantation as a promising therapeutic strategy for ischemic stroke.
    Salehi MS; Pandamooz S; Safari A; Jurek B; Tamadon A; Namavar MR; Dianatpour M; Dargahi L; Azarpira N; Fattahi S; Shid Moosavi SM; Keshavarz S; Khodabandeh Z; Zare S; Nazari S; Heidari M; Izadi S; Poursadeghfard M; Borhani-Haghighi A
    CNS Neurosci Ther; 2020 Jul; 26(7):670-681. PubMed ID: 32281225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-mesenchymal stem cells modulate microglial activation in the peri-infarct area in rats during the acute phase of stroke.
    Li Z; Ye H; Cai X; Sun W; He B; Yang Z; Xu P
    Brain Res Bull; 2019 Nov; 153():324-333. PubMed ID: 31589902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of a Combination of Electroacupuncture and TrkB-Expressing Mesenchymal Stem Cells for Ischemic Stroke.
    Ahn SM; Kim YR; Shin YI; Ha KT; Lee SY; Shin HK; Choi BT
    Mol Neurobiol; 2019 Jan; 56(1):157-173. PubMed ID: 29682700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intra-arterial transplantation of adipose-derived stem cells on the expression of netrin-1 and its receptor DCC in the peri-infarct cortex after experimental stroke.
    Huang H; Lin F; Jiang J; Chen Y; Mei A; Zhu P
    Stem Cell Res Ther; 2017 Oct; 8(1):223. PubMed ID: 29017609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke.
    Sarmah D; Datta A; Kaur H; Kalia K; Borah A; Rodriguez AM; Yavagal DR; Bhattacharya P
    Stem Cell Rev Rep; 2022 Feb; 18(2):821-838. PubMed ID: 35112234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.